Journal article
Protonitazene detection in two cases of opioid toxicity following the use of tetrahydrocannabinol vape products in Australia
R Syrjanen, JL Schumann, JW Castle, L Sharp, A Griffiths, K Blakey, M Dutch, J Maplesden, SL Greene
Clinical Toxicology | Published : 2024
Abstract
Introduction: Protonitazene is an opioid belonging to the 2-benzylbenzimidazole structural class. We describe two cases of opioid toxicity involving the reported inhalation of a delta-9-tetrahydrocannabinol vape product in which protonitazene was detected. Case reports: Case 1 was a young male found unconscious after the reported use of a delta-9-tetrahydrocannabinol vape. He suffered two subsequent apnoeic episodes requiring bag-valve-mask ventilation before eventual recovery. Only protonitazene was detected in blood at a concentration of 0.74 µg/L. Case 2 was a young male who died shortly after being found unresponsive. The postmortem femoral blood concentrations of protonitazene and delta..
View full abstractGrants
Funding Acknowledgements
The authors thank all Emerging Drugs Network of Australia-Victoria project site investigators for their assistance in ongoing case collection and Dr Linda Glowacki and A/Prof. Dimitri Gerostamoulos from the Victorian Institute of Forensic Medicine for their analytical assistance. Additional thanks to Tom Lyons from the Victorian Department of Health for his assistance in connecting relevant cases across jurisdictions, the Queensland State Coroner Terry Ryan for granting approval to publish aspects of case 2 and Dr Li Ma the Forensic Pathologist who conducted and wrote the autopsy report for case 2.